Jerry Wisler and his wife Dee’s son Michael was diagnosed with T1D in 2004 at age 8.
Jerry spent over 30 years in the pharmaceutical industry. He was the President, C.E.O., and Co-Founder of Omthera Pharmaceuticals, which was acquired by Astra Zeneca in July 2013. Throughout his career, Jerry has held multiple executive positions, serving as President and C.E.O. of Aegerion Pharmaceuticals, Vice President of Novartis Pharmaceuticals, and the Vice President of Merck and Co, Inc. Previously, he held leadership positions on the Board of Directors for Omthera Pharmaceuticals, Aegerion Pharmaceuticals, and Thermalin Diabetes, LLC. Currently, Jerry is a member of the JDRF International Board of Directors.
Jerry received his M.B.A. in Finance and B.S. in Pharmacy from the University of Toledo.